Literature DB >> 8396658

Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.

C M Shih1, S J Lo, T Miyamura, S Y Chen, Y H Lee.   

Abstract

Hepatitis B and C viruses (HBV and HCV, respectively) are associated with acute and chronic liver diseases and hepatocellular carcinoma. To elucidate the molecular status of superinfection with these two hepatitis viruses, we cotransfected the full-length or truncated version of HCV structural genes (core and envelope 1) together with the cloned HBV DNA into a human hepatoma cell line (HuH-7). Expression of HBV-specific major transcripts (3.5 and 2.1 kb), as well as HBV antigens (hepatitis B surface antigen and hepatitis B e and core antigens), was reduced about two- to fourfold by the presence of the HCV structural genes. In addition, the secretion of HBV viral particles, including the viral nucleocapsid and mature virion, was drastically suppressed about 20-fold. Analysis of the intracellular HBV core protein-associated nucleic acid indicated that the encapsidated HBV pregenomic RNA was similarly reduced about 14-fold. Deletion analysis of the HCV structural genes demonstrated that the core gene alone or the fragment containing the core protein's N-terminal 122 amino acid residues conferred the same level of suppressive activity as the full-length structural genes. By indirect immunofluorescence, we found that the core protein of HCV was located in the cytoplasm of transfected HuH-7 cells at day 3 posttransfection and was targeted to the nucleus at day 6. Thus, the kinetics of the suppressive effect exerted by HCV constructs matched the timing of core protein entrance into the nucleus. Our results substantiate the clinical finding that HBV markers are suppressed by superinfection with HCV and further imply that this inhibitory effect may occur in the processes of transcription and encapsidation of HBV pregenomic RNA and may be mediated by the core protein of HCV. The deduced amino acid sequence of the HCV core protein has revealed that it is a basic protein which contains a putative DNA-binding motif (SPRG), as well as triplicate nuclear localization signals and several putative protein kinase A and C recognition sites. These characteristics imply that the HCV core protein can also function as a gene-regulatory protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396658      PMCID: PMC238000     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers.

Authors:  K Takeuchi; Y Kubo; S Boonmar; Y Watanabe; T Katayama; Q L Choo; G Kuo; M Houghton; I Saito; T Miyamura
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.

Authors:  J M Sánchez-Tapias; J M Barrera; J Costa; M G Ercilla; A Parés; L Comalrrena; F Soley; J Bruix; X Calvet; M P Gil
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

4.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma.

Authors:  M C Kew; M Houghton; Q L Choo; G Kuo
Journal:  Lancet       Date:  1990-04-14       Impact factor: 79.321

8.  Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.

Authors:  G Sbolli; A R Zanetti; E Tanzi; L Cavanna; G Civardi; F Fornari; M Di Stasi; L Buscarini
Journal:  J Med Virol       Date:  1990-03       Impact factor: 2.327

9.  Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms.

Authors:  S B Hwang; C Z Lee; M M Lai
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

10.  RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication.

Authors:  T Hatton; S Zhou; D N Standring
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more
  72 in total

Review 1.  Occult hepatitis B: clinical implications and treatment decisions.

Authors:  Paul Schmeltzer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Occult hepatitis B in blood donors: a description of two cases.

Authors:  Ciro Capezzuto; Eva Franchi; Simona Urbani; Luisa Romanò; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

3.  Clearance of chronic HCV infection during acute delta hepatitis.

Authors:  K Deterding; S V Pothakamuri; V Schlaphoff; J Hadem; F Metzler; M J Bahr; M P Manns; M Cornberg; H Wedemeyer
Journal:  Infection       Date:  2007-12-14       Impact factor: 3.553

4.  Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.

Authors:  Xiaoming Cheng; Takuro Uchida; Yuchen Xia; Regina Umarova; Chun-Jen Liu; Pei-Jer Chen; Anuj Gaggar; Vithika Suri; Marcus M Mücke; Johannes Vermehren; Stefan Zeuzem; Yuji Teraoka; Mitsutaka Osawa; Hiroshi Aikata; Keiji Tsuji; Nami Mori; Shuhei Hige; Yoshiyasu Karino; Michio Imamura; Kazuaki Chayama; T Jake Liang
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 5.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

6.  Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

Authors:  E Rodríguez-Iñigo; J Bartolomé; N Ortiz-Movilla; C Platero; J M López-Alcorocho; M Pardo; I Castillo; V Carreño
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.

Authors:  G Barba; F Harper; T Harada; M Kohara; S Goulinet; Y Matsuura; G Eder; Z Schaff; M J Chapman; T Miyamura; C Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 8.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

9.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  The native form and maturation process of hepatitis C virus core protein.

Authors:  K Yasui; T Wakita; K Tsukiyama-Kohara; S I Funahashi; M Ichikawa; T Kajita; D Moradpour; J R Wands; M Kohara
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.